Fig 1.
Flow diagram of pediatric patients included in the analysis (n = 170).
Table 1.
Baseline characteristics at initial diagnosis of Kawasaki disease.
Table 2.
Management of CAAs at different risk levels.
Fig 2.
Kaplan-Meier estimates of the intervention-free rate of patients with Kawasaki disease who had coronary artery aneurysms (CAAs) (n = 170); small CAAs (n = 74; blue line), medium CAAs (n = 47; green line), and giant CAAs (n = 49; black line) from the time of initial diagnosis.
Fig 3.
Kaplan-Meier estimates of the cardiac event-free survival of patients with Kawasaki disease who had coronary artery aneurysms (CAAs) (n = 170); patients without giant CAAs (n = 121; blue line), and with giant CAAs (n = 49; green line) from time of initial KD diagnosis.
Fig 4.
Progression and regression of coronary artery aneurysms (CAAs) until the most recent follow-up visit (n = 170).
Table 3.
Risk analysis of major adverse cardiac events (MACE) in Kawasaki disease with coronary aneurysms (CAAs).